Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial. Issue 4 (6th February 2023)

Record Type:: Journal Article
Title:: Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial. Issue 4 (6th February 2023)
Main Title:: Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial
Authors:: Wei, Andrew H.
Döhner, Hartmut
Sayar, Hamid
Ravandi, Farhad
Montesinos, Pau
Dombret, Hervé
Selleslag, Dominik
Porkka, Kimmo
Jang, Jun‐Ho
Skikne, Barry
Beach, C. L.
Prebet, Thomas
Zhang, George
Risueño, Alberto
Ugidos, Manuel
See, Wendy L.
Menezes, Daniel
Roboz, Gail J.
Abstract:
Is Part Of:: American journal of hematology. Volume 98:Issue 4(2023)
Journal:: American journal of hematology
Issue:: Volume 98:Issue 4(2023)
Issue Display:: Volume 98, Issue 4 (2023)
Year:: 2023
Volume:: 98
Issue:: 4
Issue Sort Value:: 2023-0098-0004-0000
Page Start:: E84
Page End:: E87
Publication Date:: 2023-02-06
Subjects:: Hematology -- Periodicals
616.15
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/ajh.26847 ↗
Languages:: English
ISSNs:: 0361-8609
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 26389.xml